The proto-oncogene BCL-6 in normal and malignant B cell development
about
sameAs
Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expressionSuppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.The role of DNA breaks in genomic instability and tumorigenesis.Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancerEPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblastsRac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promotersRepression of BCL-6 is required for the formation of human memory B cells in vitro.Follicular lymphoma transforming into anaplastic diffuse large B-cell lymphoma of oral cavity: A case report with review of literature.Sirtuins: critical regulators at the crossroads between cancer and aging.Rac1 signaling modulates BCL-6-mediated repression of gene transcription.TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic miceThe dual role of sirtuins in cancer.Primary diffuse large B-cell lymphoma in the anterior hard palate: A rare case report with review of literatureAdvances in Pathobiology of Primary Central Nervous System LymphomaSomatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
P2860
Q24801814-5B3AB6D4-5DD0-40D9-95F7-015B8E20BC13Q35145901-4AF4F577-8012-401C-AEC7-740A7A66FA82Q35170919-32E85C4C-A3F4-481D-B9A7-1D57C95CAAD3Q35782978-95FB92E7-B1FE-40CC-AEE6-7C93D869E176Q36007623-A3D13BBC-986E-4F40-AE5D-4196F9B22EEDQ36228634-D394DBF1-4F50-4D9B-A975-B2C0BD9B3AD8Q36229240-25D22725-F541-4F82-BD9A-D304D5F5E57DQ36639724-8AA33037-A580-4AC8-B88F-4040A22E926AQ36908428-DD5C9E67-971D-4ED5-8EC0-25DF1D9B69C7Q37275178-D8A9FA79-23F2-4DF9-8C91-37360CAE5ACCQ37692413-C91B2775-97C4-493F-B525-3EA4A64E389BQ37937462-3C8ACD2D-78C4-4252-98A4-BA513637B7B0Q38222738-622DB618-80C2-4374-BFD1-6CFBCA2426A7Q38641508-9A43E9DF-013E-487A-865F-EDC5ECF02BCAQ43038575-9BAB3419-4B61-4A4D-AD9F-ED3E5F9011A8Q44526157-03000591-A13D-44F3-B6A9-96FEFE020177
P2860
The proto-oncogene BCL-6 in normal and malignant B cell development
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The proto-oncogene BCL-6 in normal and malignant B cell development
@ast
The proto-oncogene BCL-6 in normal and malignant B cell development
@en
The proto-oncogene BCL-6 in normal and malignant B cell development
@nl
type
label
The proto-oncogene BCL-6 in normal and malignant B cell development
@ast
The proto-oncogene BCL-6 in normal and malignant B cell development
@en
The proto-oncogene BCL-6 in normal and malignant B cell development
@nl
prefLabel
The proto-oncogene BCL-6 in normal and malignant B cell development
@ast
The proto-oncogene BCL-6 in normal and malignant B cell development
@en
The proto-oncogene BCL-6 in normal and malignant B cell development
@nl
P2860
P356
P1476
The proto-oncogene BCL-6 in normal and malignant B cell development
@en
P2093
Huifeng Niu
P2860
P304
P356
10.1002/HON.689
P407
P577
2002-12-01T00:00:00Z